Showing results (691-700 of 767) with videos related to
Sort By:
Pageof 77
Advances in Cancer Research|February 7, 2018
New Insights Into Beclin-1: Evolution and Pan-Malignancy Inhibitor ActivityStephen L Wechman, Anjan K Pradhan, Rob DeSalle, et al.Advances in Cancer Research|April 4, 2020
Race differences in mobility status among prostate cancer survivors: The role of socioeconomic statusRoland J Thorpe, Marino A Bruce, Daniel L Howard, et al.Advances in Cancer Research|April 4, 2020
Patient barriers to cancer clinical trial participation and navigator activities to assistKathleen B Cartmell, Heather S Bonilha, Kit N Simpson, et al.Advances in Cancer Research|February 1, 2022
Pan-RAS inhibitors: Hitting multiple RAS isozymes with one stoneAlexander B Coley, Antonio Ward, Adam B Keeton, et al.Advances in Cancer Research|February 1, 2022
Inhibition of SHP2 as an approach to block RAS-driven cancersYu-Ting Chou, Trever G BivonaAdvances in Cancer Research|February 1, 2022
Targeting the "undruggable" RAS with biologicsMichael Whaby, Imran Khan, John P O'BryanAdvances in Cancer Research|February 1, 2022
Drug targeting opportunities en route to Ras nanoclustersKarolina Pavic, Rohan Chippalkatti, Daniel AbankwaAdvances in Cancer Research|April 23, 2022
Predictive value of collagen in cancerPeggi M Angel, Stephen C ZambrzyckiAdvances in Cancer Research|June 27, 2018
Supramolecular Analytical Chemistry in Cancer ResearchShiqun Shao, Min XueAdvances in Cancer Research|June 27, 2018
Gold Nanoparticles for the Delivery of Cancer TherapeuticsDean M Connor, Ann-Marie BroomePageof 77